186 related articles for article (PubMed ID: 17713553)
1. T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation.
Ishii T; Zhao Y; Shi J; Sozer S; Hoffman R; Xu M
Leukemia; 2007 Dec; 21(12):2433-41. PubMed ID: 17713553
[TBL] [Abstract][Full Text] [Related]
2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
3. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum.
Muller EW; de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E
Exp Hematol; 1993 Sep; 21(10):1353-7. PubMed ID: 7689483
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.
Corre-Buscail I; Pineau D; Boissinot M; Hermouet S
Exp Hematol; 2005 Nov; 33(11):1299-308. PubMed ID: 16263414
[TBL] [Abstract][Full Text] [Related]
7. In polycythemia vera human interleukin 3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin.
de Wolf JT; Beentjes JA; Esselink MT; Smit JW; Halie RM; Clark SC; Vellenga E
Exp Hematol; 1989 Oct; 17(9):981-3. PubMed ID: 2673832
[TBL] [Abstract][Full Text] [Related]
8. Erythroid progenitors in polycythemia vera demonstrate a different response pattern to IL-4 compared to the normal BFU-E from peripheral blood.
de Wolf JT; Hendriks DW; Beentjes JA; Esselink MT; Smit JW; Halie MR; Vellenga E
Exp Hematol; 1991 Oct; 19(9):888-92. PubMed ID: 1893965
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera.
Geissler K; Ohler L; Födinger M; Kabrna E; Kollars M; Skoupy S; Lechner K
Blood; 1998 Sep; 92(6):1967-72. PubMed ID: 9731054
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
15. The effects of IL-1 and IL-4 on the Epo-independent erythroid progenitor in polycythaemia vera.
de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E
Br J Haematol; 1994 Oct; 88(2):242-6. PubMed ID: 7803266
[TBL] [Abstract][Full Text] [Related]
16. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
Kawano Y; Takaue Y; Hirao A; Sato J; Abe T; Suzue T; Saito S; Okamoto Y; Kuroda Y
Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
[TBL] [Abstract][Full Text] [Related]
17. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
18. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
Lu L; Leemhuis T; Srour EF; Yang YC
Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
[TBL] [Abstract][Full Text] [Related]
19. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
20. Soluble factors from peripheral blood T-cells of patients with polycythemia vera stimulate normal BFU-E.
Cassel A; Braester A; Quitt M; Froom P; Aghai E
Leukemia; 1993 Sep; 7(9):1370-3. PubMed ID: 8371588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
